SlideShare ist ein Scribd-Unternehmen logo
1 von 35
Downloaden Sie, um offline zu lesen
Pheochromocytoma
Dr. Rajshree Singh
Intern doctor
Shree Birendra Hospital
Chaunni, Kathmanu
Outline
• Anatomy
• Embryology
• Physiology &
biochemistry
• Disease of adrenal
gland
• Pheochromocytoma
– Introduction
– Epidemiology
– Risk factors
– Clinical features
– Investigation
– Treatment
• Case presentation
• Published papers and
researches
• References
Anatomy
Anatomy
• measures 5 x 3 x 1 cm and weighs 4 to 5 g
• Right gland is pyramidal shaped ; in close proximity to
the right hemidiaphragm, liver, and inferior vena cava
(IVC)
• Left adrenal is closely associated with the aorta,spleen,
and tail of the pancreas.
• Divided into
– Cortex—85%
– Medulla—15%
Embryology
• Mesodermal cells form the adrenal cortex
• Neuroectodermal cells migrate to the cortex from
the neural crest during embryogenesis and form the
adrenal medulla.
• neural crest cells also migrate to the para-aortic and
paravertebral areas
• Most extra-adrenal neural tissue regresses but may
persist at several sites.
Embryology
• Largest of these is located
to the left of the aortic
bifurcation near the
inferior mesenteric artery
origin and is designated
as the organ of
Zuckerkandl.
• Adrenal medullary tissue
also may be found in
neck, urinary bladder, and
para-aortic regions.
Physiology
• Adrenal cortex contains three layers:
– Zona glomerulosa secretes mineralocorticoids.
– Zona fasciculata secretes glucocorticoids.
– Zona reticularis secretes sex hormones.
• Adrenal medulla
– up to 10 to 20% of the gland's volume and is reddish
brown in color
– produces the catecholamine : epinephrine and
norepinephrine.
– cells are arranged in cords and are polyhedral in shape
– often are referred to as chromaffin cells because they
stain specifically with chromium salts.
Physiology
• Phenylethanolamine N-methyltransferase, which
converts norepinephrine to epinephrine, is only
present in the adrenal medulla and the organ of
Zuckerkandl.
• Catecholamines are stored in granules called
chromogranins.
• Hormonal secretion is stimulated by various stress
stimuli.
• In the circulation, these proteins are bound to
albumin.
Physiology
• Catecholamines are cleared by reuptake by
sympathetic nerve endings & peripheral inactivation
by catechol O-methyltransferase and monoamine
oxidase & excretion by kidneys.
• Metabolism of catecholamines takes place in the
liver and kidneys by the formation of metabolites
such as metanephrines, normetanephrines, and
VMA, which may undergo further glucuronidation or
sulfation before being excreted in the urine
Disease of adrenal glands
Adrenal cortex
• Incidentaloma
• Non-functioning adenoma
• Cushing’s adenoma
• Adrenocortical carcinoma
• Myelolipoma
• Cyst
• Metastases
• Conn’s adenoma
Adrenal medulla
• Pheochromocytoma
• Malignant
pheochromocytoma
• Neuroblastoma
Pheochromocytoma
• It is a tumour arising from chromaffin cells, from the
adrenal medulla but can also arise from extraadrenal
chromaffin tissues (Organ of Zuckerkandl).
• It is catecholamine secreting tumours
• Pheochromocytomas were first identified by Frankel in
1885, but were not named as such until 1912 by Pick,
who noted the characteristic chromaffin reaction of
the tumor cells.
• The first successful adrenalectomies for
pheochromocytoma were performed by Roux in
Switzerland, and Charles Mayo in the United States.
Epidemiology
• prevalence of phaeochromocytoma in patients
with hypertension is 0.1–0.6 per cent
• an overall prevalence of 0.05 per cent in autopsy
series.
• In total, 4 per cent of incidentalomas are
phaeochromocytomas.
• They can occur at any age with a peak incidence
in the fourth and fifth decades of life
• Have no gender predilection
the 10 percent tumor
• 10% are bilateral
• 10% are malignant
• 10% occur in pediatric patients
• 10% are extra-adrenal
• 10% are familial
• 10% multiple
• 10% not associated with hypertension
• 10% calcified
Risk factors
• occur in families with MEN2A and MEN2B, in
approximately 50% of patients
• von Hippel-Lindau (VHL) disease
• included within the tumor spectrum of
neurofibromatosis type 1 (NF1 gene) and other
neuroectodermal disorders (Sturge-Weber syndrome
and tuberous sclerosis), Carney's syndrome, MEN1
syndrome
• familial paraganglioma & pheochromocytoma syndrome
caused by mutations in the succinyl dehydrogenase
family of genes (SDHB, SDHC, and SDHD).
Clinical features
• classic triad : Headache, palpitations, and diaphoresis
• Commonest presentation is severe headache.
• Symptoms of sympathetic over activity such as
anxiety, tremulousness, paresthesias, flushing, ,
weakness, pallor, blurred vision, chest pain,
shortness of breath, abdominal pain, nausea,
vomiting, and others are nonspecific and may be
episodic in nature.
• Symptoms can be incited by a range of stimuli
including exercise, micturition, and defecation
Symptoms
Clinical Signs
• most common clinical sign is hypertension.
• Pheochromocytomas are one of the few curable
causes of hypertension and are found in 0.1 to
0.2% of hypertensive patients.
• Hypertension related to this tumor may be
paroxysmal with intervening normotension,
sustained with paroxysms or sustained
hypertension alone.
• As an abdominal mass which is nonmobile,
smooth, does not move with respiration, crossing
the midline
Complications
• Cardiovascular complications such as
myocardial infarction and arrhythmias
• Sudden death may occur in patients with
undiagnosed tumors who undergo other
surgeries or biopsy.
• precipitate hypertensive encephalopathy &
cerebral haemorrhage.
• Panic attacks
Differential diagnosis
• Hyperthyroidism
• Anxiety status
• Cardiac conditions
• Carcinoids (functioning)
Investigations
• 24-hour urine samples for catecholamines and their
metabolites
• plasma metanephrine levels.
• Urinary metanephrines are highly senisitive &
specific, whereas VMA measurements are slightly
less in so.
• False-positive VMA tests may result from ingestion of
caffeine, raw fruits, or medications ( -methyldopa).
• Fractionated urinary catecholamines also are very
sensitive but less specific for pheochromocytomas.
Investigations
• Many physiologic and pathologic states can alter the
levels of plasma catecholamines. Hence, they are
less accurate than urinary tests.
• Both epinephrine and norepinephrine should be
measured, as tumors often secrete one or the other
hormone. They have cutoff values of 2000 pg/mL for
norepinephrine and 200 pg/mL for epinephrine.
• Clonidine is an agent that suppresses neurogenically
mediated catecholamine excess but not secretion
from pheochromocytomas.
Investigations
• A normal clonidine suppression test is defined by a
decrease of basal catecholamine levels to <500 pg/mL
within 2 to 3 hours after an oral dose of 0.3 mg of
clonidine.
• Chromogranin A is a monomeric, acidic protein, which is
stored in the adrenal medulla and other neuroendocrine
tumors and released along with catecholamine
hormones. It is useful in conjunction with catecholamine
measurement for diagnosing pheochromocytomas.
• Recent studies have shown that plasma metanephrines
are the most reliable tests to identify
pheochromocytomas, with sensitivity approaching 100%.
• Add the table with cutoff biochemical values
which is table 41-4
Radiologic Studies
• CT scans are 85 to 95% sensitive and 70 to 100%
specific for pheochromocytomas.
• Images should include the region from the
diaphragm to the aortic bifurcation so as to include
the organ of Zuckerkandl.
• CT scans do not provide functional information and
cannot definitively diagnose pheochromocytomas.
• MRI scans are 95% sensitive and almost 100%
specific for pheochromocytomas because these
tumors have a characteristic appearance on T2-
weighted images or after gadolinium.
A left-sided pheochromocytoma (arrows) imaged by a
computed tomography scan of the abdomen
Pheochromocytoma
Radiologic Studies
• Metaiodobenzylguanidine (MIBG) is taken up and
concentrated by vesicles in the adrenal medullar cells
because its structure is similar to norepinephrine.
• Normal adrenal medullary tissue does not take up
appreciable MIBG.
• 131I radiolabeled MIBG is, therefore, useful for
localizing pheochromocytomas, especially those in
ectopic positions.
• This test has a reported sensitivity of 77 to 89% and
specificity ranging from 88 to 100%.
A left-sided pheochromocytoma (arrows)
MIBG scan viewed posteriorly
Treatment
Pheochromocytoma
Malignant pheochromocytoma
Case presentation
Newer concepts in approach to
Pheochromocytoma
References
• Sabiston Textbook of Surgery, 20th edition
• Schwartz's Principles of Surgery, 9th Edition
• Bailey And Love's Short Practice of Surgery
26th Ed
• SRB's Manual of Surgery, 4E
• PubMed
Thank you

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Hyperosmolar hyperglycemic state
Hyperosmolar hyperglycemic stateHyperosmolar hyperglycemic state
Hyperosmolar hyperglycemic state
 
Hyperaldosteronism
HyperaldosteronismHyperaldosteronism
Hyperaldosteronism
 
Hepatorenal syndrome
Hepatorenal syndromeHepatorenal syndrome
Hepatorenal syndrome
 
Multiple endocrine neoplasia (men) syndromes
Multiple endocrine neoplasia (men) syndromesMultiple endocrine neoplasia (men) syndromes
Multiple endocrine neoplasia (men) syndromes
 
Hypercalcemia
HypercalcemiaHypercalcemia
Hypercalcemia
 
Myxedema coma
Myxedema comaMyxedema coma
Myxedema coma
 
Upper Gastrointestinal bleeding
Upper Gastrointestinal bleedingUpper Gastrointestinal bleeding
Upper Gastrointestinal bleeding
 
NEPHRITIC SYNDROME / APSGN IN CHILDREN
NEPHRITIC SYNDROME / APSGN IN CHILDREN NEPHRITIC SYNDROME / APSGN IN CHILDREN
NEPHRITIC SYNDROME / APSGN IN CHILDREN
 
Hepatic Encephalopathy -Pathophysiology,Evaluation And Management
Hepatic Encephalopathy -Pathophysiology,Evaluation And ManagementHepatic Encephalopathy -Pathophysiology,Evaluation And Management
Hepatic Encephalopathy -Pathophysiology,Evaluation And Management
 
Paraneoplastic syndromes
Paraneoplastic syndromesParaneoplastic syndromes
Paraneoplastic syndromes
 
Sickle cell disease
Sickle cell diseaseSickle cell disease
Sickle cell disease
 
Diabetes ketoacidosis
Diabetes ketoacidosisDiabetes ketoacidosis
Diabetes ketoacidosis
 
Esophageal ca
Esophageal caEsophageal ca
Esophageal ca
 
Toxic goitre
Toxic goitreToxic goitre
Toxic goitre
 
Pheochromocytoma
PheochromocytomaPheochromocytoma
Pheochromocytoma
 
chronic liver disease
chronic liver diseasechronic liver disease
chronic liver disease
 
Thyrotoxicosis
ThyrotoxicosisThyrotoxicosis
Thyrotoxicosis
 
acute pancreatitis
acute pancreatitisacute pancreatitis
acute pancreatitis
 
Hypokalemia
HypokalemiaHypokalemia
Hypokalemia
 
Primary hyperaldosteronism
Primary hyperaldosteronismPrimary hyperaldosteronism
Primary hyperaldosteronism
 

Ähnlich wie Pheochromocytoma

Lecture 9. adrenal medulla diseases
Lecture 9. adrenal medulla diseasesLecture 9. adrenal medulla diseases
Lecture 9. adrenal medulla diseasesAyub Abdi
 
Adrenal Gland Tumours and their Management
Adrenal Gland Tumours and their ManagementAdrenal Gland Tumours and their Management
Adrenal Gland Tumours and their ManagementFaisal Zia
 
Paraneoplastic Endocrine Syndrome
Paraneoplastic Endocrine SyndromeParaneoplastic Endocrine Syndrome
Paraneoplastic Endocrine SyndromeDJ CrissCross
 
Phaeochromocytoma a case
Phaeochromocytoma a casePhaeochromocytoma a case
Phaeochromocytoma a caseREKHAKHARE
 
Paraneoplastic syndrome
Paraneoplastic syndromeParaneoplastic syndrome
Paraneoplastic syndromeariva zhagan
 
Final paraneoplastic syndromes
Final paraneoplastic syndromesFinal paraneoplastic syndromes
Final paraneoplastic syndromesDrRashmiBudha
 
Pheochromocytoma abidgn.pptx
Pheochromocytoma abidgn.pptxPheochromocytoma abidgn.pptx
Pheochromocytoma abidgn.pptxAvishek Dhungana
 
SURGICAL DISORDER OF THE THYMUS AND MYASTHENIA GRAVIS.pptx
SURGICAL DISORDER OF THE THYMUS AND MYASTHENIA GRAVIS.pptxSURGICAL DISORDER OF THE THYMUS AND MYASTHENIA GRAVIS.pptx
SURGICAL DISORDER OF THE THYMUS AND MYASTHENIA GRAVIS.pptxAmos Brighton
 
Endocrine manifestations of lung cancer and its management
Endocrine manifestations of lung cancer and its managementEndocrine manifestations of lung cancer and its management
Endocrine manifestations of lung cancer and its managementSujoy Majumdar
 
Prolactinoma; updates in management
Prolactinoma; updates in management Prolactinoma; updates in management
Prolactinoma; updates in management Khaled Mohamed
 
Adrenal Medulla.ppt
Adrenal Medulla.pptAdrenal Medulla.ppt
Adrenal Medulla.pptReetuBaral
 
AdrenocorticalCa.pptx
AdrenocorticalCa.pptxAdrenocorticalCa.pptx
AdrenocorticalCa.pptxPradeep Pande
 
PARATHYROID GLANDS AND PATHOLOGY OF IT.pptx
PARATHYROID GLANDS AND PATHOLOGY OF IT.pptxPARATHYROID GLANDS AND PATHOLOGY OF IT.pptx
PARATHYROID GLANDS AND PATHOLOGY OF IT.pptxnandithapradeep92
 
General _PARANEOPLASTIC syndromes in malignancy
General _PARANEOPLASTIC syndromes in malignancyGeneral _PARANEOPLASTIC syndromes in malignancy
General _PARANEOPLASTIC syndromes in malignancyshipragupta140193
 
Adrenal gland diseases and tumors
Adrenal gland diseases and tumorsAdrenal gland diseases and tumors
Adrenal gland diseases and tumorsMD Patholgoy, AFMC
 

Ähnlich wie Pheochromocytoma (20)

Lecture 9. adrenal medulla diseases
Lecture 9. adrenal medulla diseasesLecture 9. adrenal medulla diseases
Lecture 9. adrenal medulla diseases
 
Men 2
Men 2Men 2
Men 2
 
Adrenal Gland Tumours and their Management
Adrenal Gland Tumours and their ManagementAdrenal Gland Tumours and their Management
Adrenal Gland Tumours and their Management
 
Paraneoplastic Endocrine Syndrome
Paraneoplastic Endocrine SyndromeParaneoplastic Endocrine Syndrome
Paraneoplastic Endocrine Syndrome
 
Phaeochromocytoma a case
Phaeochromocytoma a casePhaeochromocytoma a case
Phaeochromocytoma a case
 
Paraneoplastic syndrome
Paraneoplastic syndromeParaneoplastic syndrome
Paraneoplastic syndrome
 
Final paraneoplastic syndromes
Final paraneoplastic syndromesFinal paraneoplastic syndromes
Final paraneoplastic syndromes
 
Pheochromocytoma abidgn.pptx
Pheochromocytoma abidgn.pptxPheochromocytoma abidgn.pptx
Pheochromocytoma abidgn.pptx
 
Neuroblastoma
NeuroblastomaNeuroblastoma
Neuroblastoma
 
SURGICAL DISORDER OF THE THYMUS AND MYASTHENIA GRAVIS.pptx
SURGICAL DISORDER OF THE THYMUS AND MYASTHENIA GRAVIS.pptxSURGICAL DISORDER OF THE THYMUS AND MYASTHENIA GRAVIS.pptx
SURGICAL DISORDER OF THE THYMUS AND MYASTHENIA GRAVIS.pptx
 
Endocrine manifestations of lung cancer and its management
Endocrine manifestations of lung cancer and its managementEndocrine manifestations of lung cancer and its management
Endocrine manifestations of lung cancer and its management
 
Prolactinoma; updates in management
Prolactinoma; updates in management Prolactinoma; updates in management
Prolactinoma; updates in management
 
THYROID GLAND.pptx
THYROID GLAND.pptxTHYROID GLAND.pptx
THYROID GLAND.pptx
 
Adrenal Medulla.ppt
Adrenal Medulla.pptAdrenal Medulla.ppt
Adrenal Medulla.ppt
 
Thyroid
ThyroidThyroid
Thyroid
 
AdrenocorticalCa.pptx
AdrenocorticalCa.pptxAdrenocorticalCa.pptx
AdrenocorticalCa.pptx
 
PARATHYROID GLANDS AND PATHOLOGY OF IT.pptx
PARATHYROID GLANDS AND PATHOLOGY OF IT.pptxPARATHYROID GLANDS AND PATHOLOGY OF IT.pptx
PARATHYROID GLANDS AND PATHOLOGY OF IT.pptx
 
General _PARANEOPLASTIC syndromes in malignancy
General _PARANEOPLASTIC syndromes in malignancyGeneral _PARANEOPLASTIC syndromes in malignancy
General _PARANEOPLASTIC syndromes in malignancy
 
Adrenal gland diseases and tumors
Adrenal gland diseases and tumorsAdrenal gland diseases and tumors
Adrenal gland diseases and tumors
 
Pheochromocytoma.pdf
Pheochromocytoma.pdfPheochromocytoma.pdf
Pheochromocytoma.pdf
 

Mehr von rashree-singh

Adaptations of cellular growth and diffrentiation
Adaptations of cellular growth and diffrentiationAdaptations of cellular growth and diffrentiation
Adaptations of cellular growth and diffrentiationrashree-singh
 
Consent in surgical patient
Consent in surgical patientConsent in surgical patient
Consent in surgical patientrashree-singh
 
Galeazzi fracture dislocation
Galeazzi fracture  dislocationGaleazzi fracture  dislocation
Galeazzi fracture dislocationrashree-singh
 
Oxygen toxicity and it’s mechanism
Oxygen toxicity and it’s mechanismOxygen toxicity and it’s mechanism
Oxygen toxicity and it’s mechanismrashree-singh
 
Clinical picture of Rabies
Clinical picture of RabiesClinical picture of Rabies
Clinical picture of Rabiesrashree-singh
 
pediatric Systemic lupus erythematosus
pediatric Systemic lupus erythematosuspediatric Systemic lupus erythematosus
pediatric Systemic lupus erythematosusrashree-singh
 

Mehr von rashree-singh (8)

Hydronephrosis
HydronephrosisHydronephrosis
Hydronephrosis
 
Adaptations of cellular growth and diffrentiation
Adaptations of cellular growth and diffrentiationAdaptations of cellular growth and diffrentiation
Adaptations of cellular growth and diffrentiation
 
Consent in surgical patient
Consent in surgical patientConsent in surgical patient
Consent in surgical patient
 
Galeazzi fracture dislocation
Galeazzi fracture  dislocationGaleazzi fracture  dislocation
Galeazzi fracture dislocation
 
Oxygen toxicity and it’s mechanism
Oxygen toxicity and it’s mechanismOxygen toxicity and it’s mechanism
Oxygen toxicity and it’s mechanism
 
Clinical picture of Rabies
Clinical picture of RabiesClinical picture of Rabies
Clinical picture of Rabies
 
Hydrocephalus
HydrocephalusHydrocephalus
Hydrocephalus
 
pediatric Systemic lupus erythematosus
pediatric Systemic lupus erythematosuspediatric Systemic lupus erythematosus
pediatric Systemic lupus erythematosus
 

Kürzlich hochgeladen

Disability & Inclusion Training for health professionals.pptx
Disability & Inclusion Training for health professionals.pptxDisability & Inclusion Training for health professionals.pptx
Disability & Inclusion Training for health professionals.pptxtilahun36
 
Introduction-to-Artificial-Intelligence-in-Public-Health.pptx
Introduction-to-Artificial-Intelligence-in-Public-Health.pptxIntroduction-to-Artificial-Intelligence-in-Public-Health.pptx
Introduction-to-Artificial-Intelligence-in-Public-Health.pptxspmdoc
 
World Autism Awareness day describin.ppt
World Autism Awareness day describin.pptWorld Autism Awareness day describin.ppt
World Autism Awareness day describin.pptShifaSikri3
 
2024 Natural Therapeutic Factos NTF Lazzerini Appoint Images and ChatGPT.pdf
2024 Natural Therapeutic Factos NTF Lazzerini Appoint Images and ChatGPT.pdf2024 Natural Therapeutic Factos NTF Lazzerini Appoint Images and ChatGPT.pdf
2024 Natural Therapeutic Factos NTF Lazzerini Appoint Images and ChatGPT.pdffabiolazzerini1
 
21 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 202421 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 2024Traumasoft LLC
 
immunization-Vaccines,National immunization schedule.pptx
immunization-Vaccines,National immunization schedule.pptximmunization-Vaccines,National immunization schedule.pptx
immunization-Vaccines,National immunization schedule.pptxanantaadityashivam
 
MAGNETIC RESONANCE IMAGING QUESTION AND ANSWER 3 MARKS.pdf
MAGNETIC RESONANCE IMAGING QUESTION AND ANSWER 3 MARKS.pdfMAGNETIC RESONANCE IMAGING QUESTION AND ANSWER 3 MARKS.pdf
MAGNETIC RESONANCE IMAGING QUESTION AND ANSWER 3 MARKS.pdfGanesan Yogananthem
 
Blood(The Applied Physiology) for Nurses.pptx
Blood(The Applied Physiology) for Nurses.pptxBlood(The Applied Physiology) for Nurses.pptx
Blood(The Applied Physiology) for Nurses.pptxNagamani Manjunath
 
Health literacies in marginalised communities LILAC 24.pptx
Health literacies in marginalised communities LILAC 24.pptxHealth literacies in marginalised communities LILAC 24.pptx
Health literacies in marginalised communities LILAC 24.pptxPamela McKinney
 
Dermatology diseases Index 2024 (most updated).pdf
Dermatology diseases Index 2024 (most updated).pdfDermatology diseases Index 2024 (most updated).pdf
Dermatology diseases Index 2024 (most updated).pdfjohnpaulo33
 
Unit I - Statistical parameter estimation.pptx
Unit I - Statistical parameter estimation.pptxUnit I - Statistical parameter estimation.pptx
Unit I - Statistical parameter estimation.pptxsneha_pharmacist
 
QUALITY ASSURANCE .. quality assurance and quality control.
QUALITY ASSURANCE .. quality assurance and quality control.QUALITY ASSURANCE .. quality assurance and quality control.
QUALITY ASSURANCE .. quality assurance and quality control.Talal Albudayri
 
Sensitive analysis - Unit I (Computer aided drug development.pptx
Sensitive analysis - Unit I (Computer aided drug development.pptxSensitive analysis - Unit I (Computer aided drug development.pptx
Sensitive analysis - Unit I (Computer aided drug development.pptxsneha_pharmacist
 
Handing Taking Over by using SBAR. pptx
Handing Taking Over by using SBAR.  pptxHanding Taking Over by using SBAR.  pptx
Handing Taking Over by using SBAR. pptxHussain278181
 
Unit 4- Therapuetic communication.pptx coomunication, process recording
Unit 4- Therapuetic communication.pptx coomunication, process recordingUnit 4- Therapuetic communication.pptx coomunication, process recording
Unit 4- Therapuetic communication.pptx coomunication, process recordingS.DHIVYALAKSHMI
 
Dr. David Greene's Guide to Healing: Unleashing PRP's Power on Blood Stem Cells
Dr. David Greene's Guide to Healing: Unleashing PRP's Power on Blood Stem CellsDr. David Greene's Guide to Healing: Unleashing PRP's Power on Blood Stem Cells
Dr. David Greene's Guide to Healing: Unleashing PRP's Power on Blood Stem CellsDr. David Greene Arizona
 
Ayurvedic Principles in Nutritional Counseling_.pptx
Ayurvedic Principles in Nutritional Counseling_.pptxAyurvedic Principles in Nutritional Counseling_.pptx
Ayurvedic Principles in Nutritional Counseling_.pptxLiam P
 

Kürzlich hochgeladen (20)

Disability & Inclusion Training for health professionals.pptx
Disability & Inclusion Training for health professionals.pptxDisability & Inclusion Training for health professionals.pptx
Disability & Inclusion Training for health professionals.pptx
 
Introduction-to-Artificial-Intelligence-in-Public-Health.pptx
Introduction-to-Artificial-Intelligence-in-Public-Health.pptxIntroduction-to-Artificial-Intelligence-in-Public-Health.pptx
Introduction-to-Artificial-Intelligence-in-Public-Health.pptx
 
Pediatric General: Different Kinds of Language
Pediatric General: Different Kinds of LanguagePediatric General: Different Kinds of Language
Pediatric General: Different Kinds of Language
 
World Autism Awareness day describin.ppt
World Autism Awareness day describin.pptWorld Autism Awareness day describin.ppt
World Autism Awareness day describin.ppt
 
2024 Natural Therapeutic Factos NTF Lazzerini Appoint Images and ChatGPT.pdf
2024 Natural Therapeutic Factos NTF Lazzerini Appoint Images and ChatGPT.pdf2024 Natural Therapeutic Factos NTF Lazzerini Appoint Images and ChatGPT.pdf
2024 Natural Therapeutic Factos NTF Lazzerini Appoint Images and ChatGPT.pdf
 
21 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 202421 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 2024
 
immunization-Vaccines,National immunization schedule.pptx
immunization-Vaccines,National immunization schedule.pptximmunization-Vaccines,National immunization schedule.pptx
immunization-Vaccines,National immunization schedule.pptx
 
MAGNETIC RESONANCE IMAGING QUESTION AND ANSWER 3 MARKS.pdf
MAGNETIC RESONANCE IMAGING QUESTION AND ANSWER 3 MARKS.pdfMAGNETIC RESONANCE IMAGING QUESTION AND ANSWER 3 MARKS.pdf
MAGNETIC RESONANCE IMAGING QUESTION AND ANSWER 3 MARKS.pdf
 
Blood(The Applied Physiology) for Nurses.pptx
Blood(The Applied Physiology) for Nurses.pptxBlood(The Applied Physiology) for Nurses.pptx
Blood(The Applied Physiology) for Nurses.pptx
 
Health literacies in marginalised communities LILAC 24.pptx
Health literacies in marginalised communities LILAC 24.pptxHealth literacies in marginalised communities LILAC 24.pptx
Health literacies in marginalised communities LILAC 24.pptx
 
Dermatology diseases Index 2024 (most updated).pdf
Dermatology diseases Index 2024 (most updated).pdfDermatology diseases Index 2024 (most updated).pdf
Dermatology diseases Index 2024 (most updated).pdf
 
Unit I - Statistical parameter estimation.pptx
Unit I - Statistical parameter estimation.pptxUnit I - Statistical parameter estimation.pptx
Unit I - Statistical parameter estimation.pptx
 
QUALITY ASSURANCE .. quality assurance and quality control.
QUALITY ASSURANCE .. quality assurance and quality control.QUALITY ASSURANCE .. quality assurance and quality control.
QUALITY ASSURANCE .. quality assurance and quality control.
 
Sensitive analysis - Unit I (Computer aided drug development.pptx
Sensitive analysis - Unit I (Computer aided drug development.pptxSensitive analysis - Unit I (Computer aided drug development.pptx
Sensitive analysis - Unit I (Computer aided drug development.pptx
 
Handing Taking Over by using SBAR. pptx
Handing Taking Over by using SBAR.  pptxHanding Taking Over by using SBAR.  pptx
Handing Taking Over by using SBAR. pptx
 
Unit 4- Therapuetic communication.pptx coomunication, process recording
Unit 4- Therapuetic communication.pptx coomunication, process recordingUnit 4- Therapuetic communication.pptx coomunication, process recording
Unit 4- Therapuetic communication.pptx coomunication, process recording
 
Dr. David Greene's Guide to Healing: Unleashing PRP's Power on Blood Stem Cells
Dr. David Greene's Guide to Healing: Unleashing PRP's Power on Blood Stem CellsDr. David Greene's Guide to Healing: Unleashing PRP's Power on Blood Stem Cells
Dr. David Greene's Guide to Healing: Unleashing PRP's Power on Blood Stem Cells
 
Pediatric Social Language: Instead of "I Don't Know"
Pediatric Social Language: Instead of "I Don't Know"Pediatric Social Language: Instead of "I Don't Know"
Pediatric Social Language: Instead of "I Don't Know"
 
The Power of Active listening - Tool in effective communication.pdf
The Power of Active listening - Tool in effective communication.pdfThe Power of Active listening - Tool in effective communication.pdf
The Power of Active listening - Tool in effective communication.pdf
 
Ayurvedic Principles in Nutritional Counseling_.pptx
Ayurvedic Principles in Nutritional Counseling_.pptxAyurvedic Principles in Nutritional Counseling_.pptx
Ayurvedic Principles in Nutritional Counseling_.pptx
 

Pheochromocytoma

  • 1. Pheochromocytoma Dr. Rajshree Singh Intern doctor Shree Birendra Hospital Chaunni, Kathmanu
  • 2. Outline • Anatomy • Embryology • Physiology & biochemistry • Disease of adrenal gland • Pheochromocytoma – Introduction – Epidemiology – Risk factors – Clinical features – Investigation – Treatment • Case presentation • Published papers and researches • References
  • 4. Anatomy • measures 5 x 3 x 1 cm and weighs 4 to 5 g • Right gland is pyramidal shaped ; in close proximity to the right hemidiaphragm, liver, and inferior vena cava (IVC) • Left adrenal is closely associated with the aorta,spleen, and tail of the pancreas. • Divided into – Cortex—85% – Medulla—15%
  • 5. Embryology • Mesodermal cells form the adrenal cortex • Neuroectodermal cells migrate to the cortex from the neural crest during embryogenesis and form the adrenal medulla. • neural crest cells also migrate to the para-aortic and paravertebral areas • Most extra-adrenal neural tissue regresses but may persist at several sites.
  • 6. Embryology • Largest of these is located to the left of the aortic bifurcation near the inferior mesenteric artery origin and is designated as the organ of Zuckerkandl. • Adrenal medullary tissue also may be found in neck, urinary bladder, and para-aortic regions.
  • 7. Physiology • Adrenal cortex contains three layers: – Zona glomerulosa secretes mineralocorticoids. – Zona fasciculata secretes glucocorticoids. – Zona reticularis secretes sex hormones. • Adrenal medulla – up to 10 to 20% of the gland's volume and is reddish brown in color – produces the catecholamine : epinephrine and norepinephrine. – cells are arranged in cords and are polyhedral in shape – often are referred to as chromaffin cells because they stain specifically with chromium salts.
  • 8. Physiology • Phenylethanolamine N-methyltransferase, which converts norepinephrine to epinephrine, is only present in the adrenal medulla and the organ of Zuckerkandl. • Catecholamines are stored in granules called chromogranins. • Hormonal secretion is stimulated by various stress stimuli. • In the circulation, these proteins are bound to albumin.
  • 9. Physiology • Catecholamines are cleared by reuptake by sympathetic nerve endings & peripheral inactivation by catechol O-methyltransferase and monoamine oxidase & excretion by kidneys. • Metabolism of catecholamines takes place in the liver and kidneys by the formation of metabolites such as metanephrines, normetanephrines, and VMA, which may undergo further glucuronidation or sulfation before being excreted in the urine
  • 10. Disease of adrenal glands Adrenal cortex • Incidentaloma • Non-functioning adenoma • Cushing’s adenoma • Adrenocortical carcinoma • Myelolipoma • Cyst • Metastases • Conn’s adenoma Adrenal medulla • Pheochromocytoma • Malignant pheochromocytoma • Neuroblastoma
  • 11. Pheochromocytoma • It is a tumour arising from chromaffin cells, from the adrenal medulla but can also arise from extraadrenal chromaffin tissues (Organ of Zuckerkandl). • It is catecholamine secreting tumours • Pheochromocytomas were first identified by Frankel in 1885, but were not named as such until 1912 by Pick, who noted the characteristic chromaffin reaction of the tumor cells. • The first successful adrenalectomies for pheochromocytoma were performed by Roux in Switzerland, and Charles Mayo in the United States.
  • 12. Epidemiology • prevalence of phaeochromocytoma in patients with hypertension is 0.1–0.6 per cent • an overall prevalence of 0.05 per cent in autopsy series. • In total, 4 per cent of incidentalomas are phaeochromocytomas. • They can occur at any age with a peak incidence in the fourth and fifth decades of life • Have no gender predilection
  • 13. the 10 percent tumor • 10% are bilateral • 10% are malignant • 10% occur in pediatric patients • 10% are extra-adrenal • 10% are familial • 10% multiple • 10% not associated with hypertension • 10% calcified
  • 14. Risk factors • occur in families with MEN2A and MEN2B, in approximately 50% of patients • von Hippel-Lindau (VHL) disease • included within the tumor spectrum of neurofibromatosis type 1 (NF1 gene) and other neuroectodermal disorders (Sturge-Weber syndrome and tuberous sclerosis), Carney's syndrome, MEN1 syndrome • familial paraganglioma & pheochromocytoma syndrome caused by mutations in the succinyl dehydrogenase family of genes (SDHB, SDHC, and SDHD).
  • 15. Clinical features • classic triad : Headache, palpitations, and diaphoresis • Commonest presentation is severe headache. • Symptoms of sympathetic over activity such as anxiety, tremulousness, paresthesias, flushing, , weakness, pallor, blurred vision, chest pain, shortness of breath, abdominal pain, nausea, vomiting, and others are nonspecific and may be episodic in nature. • Symptoms can be incited by a range of stimuli including exercise, micturition, and defecation
  • 17. Clinical Signs • most common clinical sign is hypertension. • Pheochromocytomas are one of the few curable causes of hypertension and are found in 0.1 to 0.2% of hypertensive patients. • Hypertension related to this tumor may be paroxysmal with intervening normotension, sustained with paroxysms or sustained hypertension alone. • As an abdominal mass which is nonmobile, smooth, does not move with respiration, crossing the midline
  • 18. Complications • Cardiovascular complications such as myocardial infarction and arrhythmias • Sudden death may occur in patients with undiagnosed tumors who undergo other surgeries or biopsy. • precipitate hypertensive encephalopathy & cerebral haemorrhage. • Panic attacks
  • 19. Differential diagnosis • Hyperthyroidism • Anxiety status • Cardiac conditions • Carcinoids (functioning)
  • 20. Investigations • 24-hour urine samples for catecholamines and their metabolites • plasma metanephrine levels. • Urinary metanephrines are highly senisitive & specific, whereas VMA measurements are slightly less in so. • False-positive VMA tests may result from ingestion of caffeine, raw fruits, or medications ( -methyldopa). • Fractionated urinary catecholamines also are very sensitive but less specific for pheochromocytomas.
  • 21. Investigations • Many physiologic and pathologic states can alter the levels of plasma catecholamines. Hence, they are less accurate than urinary tests. • Both epinephrine and norepinephrine should be measured, as tumors often secrete one or the other hormone. They have cutoff values of 2000 pg/mL for norepinephrine and 200 pg/mL for epinephrine. • Clonidine is an agent that suppresses neurogenically mediated catecholamine excess but not secretion from pheochromocytomas.
  • 22. Investigations • A normal clonidine suppression test is defined by a decrease of basal catecholamine levels to <500 pg/mL within 2 to 3 hours after an oral dose of 0.3 mg of clonidine. • Chromogranin A is a monomeric, acidic protein, which is stored in the adrenal medulla and other neuroendocrine tumors and released along with catecholamine hormones. It is useful in conjunction with catecholamine measurement for diagnosing pheochromocytomas. • Recent studies have shown that plasma metanephrines are the most reliable tests to identify pheochromocytomas, with sensitivity approaching 100%.
  • 23. • Add the table with cutoff biochemical values which is table 41-4
  • 24. Radiologic Studies • CT scans are 85 to 95% sensitive and 70 to 100% specific for pheochromocytomas. • Images should include the region from the diaphragm to the aortic bifurcation so as to include the organ of Zuckerkandl. • CT scans do not provide functional information and cannot definitively diagnose pheochromocytomas. • MRI scans are 95% sensitive and almost 100% specific for pheochromocytomas because these tumors have a characteristic appearance on T2- weighted images or after gadolinium.
  • 25. A left-sided pheochromocytoma (arrows) imaged by a computed tomography scan of the abdomen
  • 27. Radiologic Studies • Metaiodobenzylguanidine (MIBG) is taken up and concentrated by vesicles in the adrenal medullar cells because its structure is similar to norepinephrine. • Normal adrenal medullary tissue does not take up appreciable MIBG. • 131I radiolabeled MIBG is, therefore, useful for localizing pheochromocytomas, especially those in ectopic positions. • This test has a reported sensitivity of 77 to 89% and specificity ranging from 88 to 100%.
  • 28. A left-sided pheochromocytoma (arrows) MIBG scan viewed posteriorly
  • 33. Newer concepts in approach to Pheochromocytoma
  • 34. References • Sabiston Textbook of Surgery, 20th edition • Schwartz's Principles of Surgery, 9th Edition • Bailey And Love's Short Practice of Surgery 26th Ed • SRB's Manual of Surgery, 4E • PubMed

Hinweis der Redaktion

  1. Pheochromocytomas are rare tumors with prevalence rates ranging from 0.3 to 0.95% in autopsy series and approximately 1.9% in series using biochemical screening. They can occur at any age with a peak incidence in the fourth and fifth decades of life and have no gender predilection. Extra-adrenal tumors, also called functional paragangliomas, may be found at sites of sympathetic ganglia in the organ of Zuckerkandl, neck, mediastinum, abdomen, and pelvis. Pheochromocytomas often are called the 10 percent tumor because 10% are bilateral, 10% are malignant, 10% occur in pediatric patients, 10% are extra-adrenal, and 10% are familial. Pheochromocytomas occur in families with MEN2A and MEN2B, in approximately 50% of patients. Both syndromes are inherited in an autosomal dominant fashion and are caused by germline mutations in the RET proto-oncogene. Another syndrome with an increased risk of pheochromocytomas is von Hippel-Lindau (VHL) disease, which also is inherited in an autosomal dominant manner. This syndrome also includes retinal angioma, hemangioblastomas of the central nervous system, renal cysts and carcinomas, pancreatic cysts, and epididymal cystadenomas. The incidence of pheochromocytomas in the syndrome is approximately 14%. The gene causing VHL has been mapped to chromosome 3p and is a tumor-suppressor gene. Pheochromocytomas also are included within the tumor spectrum of neurofibromatosis type 1 (NF1 gene) and other neuroectodermal disorders (Sturge-Weber syndrome and tuberous sclerosis), Carney's syndrome (gastric epithelioid leiomyosarcoma, pulmonary chondroma, and extra-adrenal paraganglioma), MEN1 syndrome, and the familial paraganglioma and pheochromocytoma syndrome caused by mutations in the succinyl dehydrogenase family of genes (SDHB, SDHC, and SDHD).92
  2. *Fractionated urinary catecholamines also are very sensitive but less specific for pheochromocytomas.. Because extra-adrenal sites lack phenylethanolamine N-methyltransferase, these tumors secrete norepinephrine whereas epinephrine is the main hormone secreted from adrenal pheochromocytomas
  3. Schwartz says : The scans should be performed without contrast to minimize the risk of precipitating a hypertensive crisis although some recent studies suggest that IV contrast may be used. * MRI is also the study of choice in pregnant women as there is no risk of radiation exposure.